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DISSERTATION TITLE: 
ESTIMATION OF DIPEPTIDYL PEPTIDASE IV IN ORAL SQUAMOUS CELL 
CARCINOMA PATIENTS UNDERGOING RADIOTHERAPY 
AIM: 
The aim of this study is to determine the levels of Dipeptidyl peptidase IV (DPP IV) in blood 
of oral squamous cell carcinoma (OSCC) patients undergoing radiation therapy. 
 
MATERIALS AND METHODS: 
The sample for the present study comprised of 60 patients of both genders with an age 
distribution between 30 and 75 years. The study samples were divided into three groups 
which follows as; Group 1: patients who were histopathologically diagnosed with OSCC and 
undergoing radiation therapy alone (n = 20), Group 2: patients who were histopathologically 
diagnosed with OSCC and undergoing radiation therapy after surgery (n = 20) and Group3: 
normal healthy individuals with clinically normal oral mucosa (n = 20). Blood samples were 
collected twice from each patient in group 1 and 2, during 1
st
 day before radiation therapy 
(IA, IIA) and at the end of third week (21
st
 day) during radiation therapy (IB, IIB). In group 3 
blood samples were collected in the 1
st
 day (IIIA) and 21
st
 day (IIIB). 2.5 ml of blood will be 
collected by venous puncture under aseptic precautions. Obtained samples were centrifuged & 
the levels of DPP IV were analysed by proper biochemical methods. 
 
 
STATISTICAL ANALYSIS: 
All the parameters were tabulated for statistical significance using Statistical Package for 
Social Science (SPSS) software. The difference in levels of DPP IV activity in blood of 
OSCC patients undergoing only radiation therapy, OSCC patients undergoing radiation 
therapy after surgery and control group were statistically analyzed  using paired T test. 
Multiple groups were analyzed by one way ANOVA test and intergroup comparisons were 
made using Post-hoc test. P value of less than 0.05 was considered to be statistically 
significant. 
 
RESULTS: 
Statistical significance was observed in the levels of DPP IV activity in all the groups namely 
group IA, IB, IIA, IIB, IIIA and IIIB. 
 
CONCLUSION: 
In this study, DPP IV enzyme levels were found to be decreased in OSCC patients before 
radiation therapy and DPP IV enzyme levels were found to be increased during radiation 
therapy. Since DPP IV apoptotic enzymes are increased during treatment, it can be used as a 
valid, convenient and reliable diagnostic measuring biomarker. Hence it can be suggested that 
estimation of blood DPP IV using spectrophotometry method can be used as a biochemical 
marker in diagnosis as well as in prognosis of oral squamous cell carcinoma. 
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